Keyphrases
Poor Outcome
100%
Uterine Carcinosarcoma
100%
Protein Receptor
100%
Estrogen Receptor β
100%
Wilms' Tumor 1 Protein
100%
Overall Survival
88%
Wilms Tumor
77%
Progression-free Survival
66%
Confidence Interval
33%
Hazard Ratio
33%
A1 Receptor
33%
Lower Uterine Segment
22%
Immunohistochemistry
11%
Non-associated
11%
Tumor Samples
11%
Multivariate Analysis
11%
Worse Outcome
11%
Chemotherapy
11%
Malignancy
11%
Univariate Analysis
11%
Prognostic Factors
11%
Multivariate Model
11%
Radiotherapy
11%
Gynecological Cancer
11%
Retrospective Analysis
11%
Immunohistochemical Staining
11%
Carcinosarcoma
11%
Univariate Model
11%
Postoperative Treatment
11%
Immunohistochemical Scoring
11%
Beta-proteins
11%
Nursing and Health Professions
Carcinosarcoma
100%
Nephroblastoma
100%
Estrogen Receptor Beta
100%
Overall Survival
88%
Progression Free Survival
66%
Confidence Interval
33%
Hazard Ratio
33%
Neoplasm
11%
Univariate Analysis
11%
Multivariate Analysis
11%
Postoperative Care
11%
Female Genital Tract Cancer
11%
Immunohistochemistry
11%
Radiotherapy
11%
Medicine and Dentistry
Carcinosarcoma
100%
Wilms' Tumor
100%
Estrogen Receptor Beta
100%
Overall Survival
88%
Progression Free Survival
66%
Hazard Ratio
33%
Neoplasm
11%
Immunohistochemistry
11%
Cancer
11%
Univariate Analysis
11%
Multivariate Analysis
11%
Female Genital Tract Cancer
11%
Prognostic Factor
11%
Postoperative Care
11%
Radiation Therapy
11%